(Q81422392)
Statements
I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial (English)
Andrew Herstein
Kent Wallner
Gregory Merrick
Hiroki Mitsuyama
Julius Armstrong
William Cavanagh